MAYZENT .25 mg/1 (Siponimod TABLET, FILM COATED) .25 mg/1

MAYZENT 0.25 mg is a prescription medication containing siponimod, used to manage specific medical conditions. This oral tablet is designed for targeted therapeutic use, offering a convenient treatment option.

Strength

.25 mg/1

Pack Size

7 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-89)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

MAYZENT 0.25 mg tablets are primarily used for the treatment of certain autoimmune conditions. Siponimod, the active ingredient, is often prescribed to help manage symptoms and improve quality of life for patients with qualifying conditions. What is MAYZENT used for? This medication is typically used in the management of relapsing forms of a specific autoimmune disease, aiming to reduce the frequency of relapses and slow the progression of the condition.

Side Effects

Common effects of MAYZENT 0.25 mg may include fatigue, headache, and mild gastrointestinal discomfort. Some users may experience dizziness or changes in blood pressure. These effects vary among individuals and are generally mild to moderate in severity.

Precautions & Warnings

MAYZENT 0.25 mg should be handled with care, following the prescribed dosage and administration guidelines. It is important to inform your healthcare provider about any existing medical conditions or allergies before starting this medication. Regular monitoring may be required to ensure safety and efficacy.

Avoid Interactions

MAYZENT 0.25 mg may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. Alcohol and other central nervous system depressants should be avoided or used with caution. Always consult a healthcare provider before combining MAYZENT with other medications.

Frequently Asked Questions

MAYZENT 0.25 mg is used to manage relapsing forms of a specific autoimmune condition, aiming to reduce relapse frequency and slow disease progression.

MAYZENT 0.25 mg is taken orally, typically once daily. Follow your healthcare provider's instructions for the best results.

Common side effects may include fatigue, headache, and mild gastrointestinal discomfort. Always consult a healthcare provider for personalized advice.

MAYZENT 0.25 mg may interact with certain medications. Consult your healthcare provider before combining it with other drugs.

Long-term safety of MAYZENT 0.25 mg should be discussed with a healthcare provider, who can monitor for any potential issues.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.